Biotek-snakken — November 2019
-
-
RoninDK har selv købt til gennemsnitskurs på 4,4 - og solgt 1/3 i 23 og yderligere 1/3 i 27 og har så en 1/3 tilbage som jeg i hvert fald holder ind over fase III data fra CheckMate 9ER og PDIGREE, så må vi se om det kan give luft under aktien igen

-
PCI Biotech indgår aftale med Astra Zeneca, mon ikke det kan give et løft på kursen ? https://www.marketscreener.com/PCI-BIOTECH-HOLDING-ASA-44172516/news/PCI-Biotech-Expansion-of-preclinical-research-collaboration-agreement-with-AstraZeneca-29645925/
-
-
Nordic Nanovector https://www.marketscreener.com/NORDIC-NANOVECTOR-ASA-21296150/
-
Van Herk overvejer at investere i Orphazyme: https://medwatch.dk/secure/Medicinal___Biotek/article11774785.ece
-
Biontech stiger 5% i efterhandelen. Oppe 51% siden 10 oktober https://finance.yahoo.com/quote/BNTX?p=BNTX
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
